David Charles Lubner, Director at Braveheart Bio, Inc., holds 55.55K shares in Braveheart Bio, Inc. (Ticker: BRVE), holds 0.00 shares in Dyne Therapeutics (Ticker: DYN), holds 0.00 shares in Arcellx Inc (Ticker: ACLX). Most recently, David Charles Lubner Bought ― shares of Braveheart Bio, Inc. on Aug 07, 2026 for an estimated value of $999.99K.
What is the percentage of profitable transactions made by David Charles Lubner?
The percentage of profitable transactions made by David Charles Lubner is 67%.
What is the average return per transaction made by David Charles Lubner?
The average return per transaction made by David Charles Lubner is 57.20%.
What stocks does David Charles Lubner hold?
David Charles Lubner holds: BRVE, TTPH, RARX, ~NITE, DYN, VOR, IRON, PNT, ACLX, CRGX, CBIO stocks.
What was David Charles Lubner’s latest transaction?
David Charles Lubner latest transaction was an Informative Buy of $999.99K.
What was David Charles Lubner's most profitable transaction?
David Charles Lubner’s most profitable transaction was an Informative Buy of PNT stock on November 28, 2022. The return on the trade was 109.50%.
What is David Charles Lubner's role in Braveheart Bio, Inc.?
David Charles Lubner's role in Braveheart Bio, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.